Deferataj 125mg Tablet DT
Marketer
Taj Pharma India Ltd
Salt Composition
Deferasirox (125mg)
Overview Deferataj 125mg Tablet DT
Deferasirox 125mg tablets are prescribed to manage chronic iron buildup resulting from repeated blood transfusions. This medication facilitates iron excretion, mitigating the potential for organ damage. Administer Deferasirox 125mg tablets on an empty stomach, adhering strictly to the prescribed dosage and schedule for optimal efficacy. Commonly reported side effects include nausea, headache, constipation, and diarrhea. Should these effects intensify or persist, consult your physician. Prior to commencing treatment, disclose any existing kidney or liver conditions, as well as all other medications you are currently using, to your doctor to ensure treatment safety.
Primary Ingredients of Deferataj 125mg Tablet DT
No text provided. Please provide the text you want me to rephrase.
Uses of Deferataj 125mg Tablet DT
Managing excess iron in the body
Major Benefits of Deferataj 125mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Deferataj 125mg Tablet DT in water before consumption. Administer on an empty stomach.
Common Side effects of Deferataj 125mg Tablet DT:
- Nausea
- Headache
- Vomiting
- Rash
- Abdominal pain
- Constipation
- Itching
- Abdominal distension
- Diarrhea
How to use Deferataj 125mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Deferataj 125mg Tablet DT in water before consumption. Administer on an empty stomach.
How Deferataj 125mg Tablet DT works:
Deferasirox 125mg tablets bind and eliminate surplus iron, primarily through fecal excretion, thereby mitigating the potential for organ injury.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Deferataj 125mg Tablet DT is of unknown safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Deferataj 125mg Tablet DT during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Deferataj 125mg Tablet DT while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking a Deferataj 125mg Tablet DT might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyUNSAFE
The use of Deferataj 125mg Tablet DT is likely inadvisable for individuals with impaired kidney function and should be avoided. Medical advice is recommended.
LiverCAUTION
Patients with hepatic impairment should use Deferataj 125mg Tablet DT cautiously, as dose modification may be necessary. Physician consultation is recommended.
What if you forget to take Deferataj 125mg Tablet DT :
Should you forget a Deferataj 125mg Tablet DT dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Deferataj 125mg Tablet DT
| Label | Value |
|---|---|
| Chemical Category | Benzoate-triazole hybrid |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
3,018 People bought this recently